Why drug manufacturing needs to become more flexible
More standards leading to leaner processes
Digital transformation does not stop at the pharmaceutical industry. But until Pharma 4.0 can become socially acceptable, it will first and foremost be necessary to define globally uniform standards. This is going to take time. Time which the industry does not have in view of the speed of development at Google and Amazon and their penetration of the healthcare market. The White Paper gives a brief overview of the way in which structures have evolved over time and places them in the context of current technological developments in drug production.
You will learn the following:
- How the interface landscape is formed in many pharmaceutical companies.
- Why common standards will be indispensable in the future.
- How Pharma 4.0 solutions can also be implemented with structures that have grown non-organically.
- What strategy Stäubli as a company is pursuing in regard to digital transformation.
- Which of the robot manufacturer’s technological developments are helping to make automated production futureproof.
White Paper classification
Download white paper now
Why drug manufacturing needs to become more flexible
More standards leading to leaner processes
You may also be interested in these white papers
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
